217 related articles for article (PubMed ID: 21933201)
1. Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.
Prisciandaro JJ; DeSantis SM; Chiuzan C; Brown DG; Brady KT; Tolliver BK
Alcohol Clin Exp Res; 2012 Mar; 36(3):490-6. PubMed ID: 21933201
[TBL] [Abstract][Full Text] [Related]
2. Commentary on the study: impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate (Prisciandaro et al.).
Preuss UW
Alcohol Clin Exp Res; 2012 Jun; 36(6):967-9. PubMed ID: 22563952
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.
Tolliver BK; Desantis SM; Brown DG; Prisciandaro JJ; Brady KT
Bipolar Disord; 2012 Feb; 14(1):54-63. PubMed ID: 22329472
[TBL] [Abstract][Full Text] [Related]
4. Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial.
Prisciandaro JJ; Brown DG; Brady KT; Tolliver BK
Psychiatry Res; 2011 Aug; 188(3):361-5. PubMed ID: 21641663
[TBL] [Abstract][Full Text] [Related]
5. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
6. Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study.
Leggio L; Ray LA; Kenna GA; Swift RM
Alcohol Clin Exp Res; 2009 Sep; 33(9):1539-44. PubMed ID: 19485973
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.
Brown ES; Davila D; Nakamura A; Carmody TJ; Rush AJ; Lo A; Holmes T; Adinoff B; Caetano R; Swann AC; Sunderajan P; Bret ME
Alcohol Clin Exp Res; 2014 Jul; 38(7):2113-8. PubMed ID: 24976394
[TBL] [Abstract][Full Text] [Related]
8. Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.
Ralevski E; O'Brien E; Jane JS; Dean E; Dwan R; Petrakis I
J Nerv Ment Dis; 2011 Jul; 199(7):499-505. PubMed ID: 21716064
[TBL] [Abstract][Full Text] [Related]
9. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
[TBL] [Abstract][Full Text] [Related]
10. Moderating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependence.
Witkiewitz K; Bowen S; Donovan DM
J Consult Clin Psychol; 2011 Feb; 79(1):54-63. PubMed ID: 21261434
[TBL] [Abstract][Full Text] [Related]
11. The effect of acamprosate on alcohol and food craving in patients with alcohol dependence.
Han DH; Lyool IK; Sung YH; Lee SH; Renshaw PF
Drug Alcohol Depend; 2008 Mar; 93(3):279-83. PubMed ID: 17983709
[TBL] [Abstract][Full Text] [Related]
12. The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial.
Hammarberg A; Jayaram-Lindström N; Beck O; Franck J; Reid MS
Psychopharmacology (Berl); 2009 Jul; 205(1):53-62. PubMed ID: 19319508
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
[TBL] [Abstract][Full Text] [Related]
14. Craving as a predictor of treatment outcomes in heavy drinkers with comorbid depressed mood.
Connolly JM; Kavanagh DJ; Baker AL; Kay-Lambkin FJ; Lewin TJ; Davis PJ; Quek LH
Addict Behav; 2013 Feb; 38(2):1585-1592. PubMed ID: 22727783
[TBL] [Abstract][Full Text] [Related]
15. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
[TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of outcome from an Australian pharmacological relapse prevention trial.
Morley KC; Teesson M; Sannibale C; Baillie A; Haber PS
Alcohol Alcohol; 2010; 45(6):520-6. PubMed ID: 20952764
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
18. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
Gual A; Lehert P
Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
[TBL] [Abstract][Full Text] [Related]
19. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.
Lejoyeux M; Lehert P
Alcohol Alcohol; 2011; 46(1):61-7. PubMed ID: 21118900
[TBL] [Abstract][Full Text] [Related]
20. Association between a brief alcohol craving measure and drinking in the following week.
McHugh RK; Fitzmaurice GM; Griffin ML; Anton RF; Weiss RD
Addiction; 2016 Jun; 111(6):1004-10. PubMed ID: 26780476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
